Abstract Background and Aims While transvenous pacemakers (TV-VVI) are standard for bradyarrhythmia, lead- and pocket-related complications remain concerns. Leadless pacemakers (LPMs) may reduce these risks. However, direct comparisons between LPMs and single-chamber TV pacemakers are limited. This study aimed to compare clinically meaningful outcomes between LPM and TV-VVI using real-world data. Methods Using the National Readmissions Database (NRD), we analyzed demographics, readmission rates, and 30-day outcomes of patients aged ≥65 years who underwent LPM or TV-VVI implantation between 2016 and 2022. Admissions were identified via ICD-10 codes. Outcomes were assessed in the propensity score–matched population (10,594 patients per group) through multivariable logistic regression after 1:1 high-dimensional propensity score matching (caliper 0.1 SD) to adjust for confounding. Results Among 49,852 patients, 44.8% received LPM. Median age was 84 vs 81 years in TV-VVI and LPM groups; 46.2% were female. TV-VVI patients had significantly higher rates of device-related complications adjusted OR (aOR): 0.45, 95% CI (0.30–0.65), P 0.001, device revision or replacement aOR: 0.20, 95% CI (0.11–0.36), P 0.001, implant-related complications aOR: 0.58, 95% CI (0.34–0.97), P = 0.040. Crude rates of arteriovenous fistula, pseudoaneurysm, and pericardial complications were higher in LPM, but adjusted differences were nonsignificant. Thirty-day readmission rates were similar between LPM and TV-VVI groups at 15.5% and 15.9%, respectively. Mortality and prolonged length of hospital stay also showed no significant differences. Conclusions Nationally representative data indicate that LPM implantation is associated with fewer device-related complications compared to TV-VVI, though further studies are needed to evaluate long-term outcomes.
He et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: